Cell Based Assay Market is Set for Strong Growth, To Reach US$ 23 Billion by 2024

1. Global Cell-Based Assay Market Research Report and Forecast Report Edition: 2019 Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved

2. About IMARC Group Report Description The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Cell-Based Assay Market Overview: According to the latest report by IMARC Group, titled “Cell-Based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global cell-based assay market reached a value of US$ 14 Billion in 2018. The cell-based assay is an analytical method used to determine the concentration of a substance by observing its effects on living organisms (in vivo) or tissues (in vitro). Unlike biochemical assays, they study intact or fixed cells instead of quantifying cell lysate. They are widely utilized in sub-cellular localization, monitoring environmental pollutants and testing cytotoxicity. Apart from this, they are also employed to evaluate a vast array of biochemical, functional and biological effects including gene activation, cell signaling, cell proliferation, antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis and necrosis. Cell-Based Assay Market Trends The increasing incidence rates of chronic diseases like cancer, diabetes and cardiovascular diseases is driving the demand for cell-based assays. For instance, they are widely used for screening mutagenesis in chronic myeloid leukemia.

4. Report Description and Highlights Report Description Apart from this, manufacturers are continually engaging in research and development (R&D) activities to formulate safer drugs using this technique, thus further contributing to the market growth. On account of the aforementioned factors, the global cell-based assay market size is projected to reach US$ 23 Billion by 2024, exhibiting a CAGR of 8.6% during 2019-2024.

5. Report Description and Highlights Report Description • Moreover, owing to technological advancements, they are now widely used for drug discovery and toxicology studies. The advent 3D cell-based assays is expected to create new growth opportunities for the market. • Key Market Segmentation: • Market Segmentation by Product and Services • Consumables • Reagents and Media • Cells and Cell Lines • Probes and Labels • Instruments • Microplates • Microplate Readers • High Throughput Screening • Liquid Handling Systems • Services • Software

6. Report Description and Highlights Report Description • Based on products, the market has been segregated into consumables, instruments, services and software. Amongst these, consumables are the most popular product in the global cell-based assay market. • Market Breakup by Technology • Automated Handling • Flow Cytometry • Label-Free Detection • High-Throughput Screening • Others • On the basis of technologies, automated handling dominates the market, followed by flow cytometry, label-free-detection, high-throughput screening and others. • Market Segmentation by Region • North America

7. Report Description and Highlights Report Description • Europe • Asia Pacific • Latin America • Middle East and Africa • Region-wise, North America enjoys the leading position in the global cell-based assay market. Other major regions are Europe, Asia Pacific, Middle East and Africa, and Latin America. • Market Segmentation by Application • Drug Discovery • Basic Research • ADME Studies • Predictive Toxicology • Others • Based on applications, drug discovery represents the largest application segment, accounting for the majority of the global share.

8. Report Description and Highlights Report Description • Drug discovery is followed by basic research, ADME studies, predictive toxicology and others. • Market Breakup by End-User • Pharmaceutical and Biotechnology Companies • Academic and Government Institutions • Contract Research Organizations • Others • The market has also been segregated on the basis of end-users into pharmaceutical and biotechnology companies, academic and government institutions and contract research organizations. Currently, pharmaceutical and biotechnology companies are the largest end-user. • Competitive Landscape: • The competitive landscape of the market has also been examined with some of the key players. • Becton Dickinson

9. Report Description and Highlights Report Description • Danaher Corporation • Thermo Fisher Scientific Inc. • General Electric Company • Merck KGaA • Perkinelmer, Inc. • Charles River Laboratories, Inc. • Lonza Group Ltd. • Cell Signaling Technology, Inc. • Promega Corporation • Cisbio Bioassays • Cell Biolabs, Inc. • Discoverx Corporation • Bio-Rad Laboratories, Inc. • Corning, Inc. • Hoffmann-La Roche Ltd Spectrum Chemical • For more information, click here: https://www.imarcgroup.com/cell-based-assays-market

10. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

11. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com